Changing the Early RMS Treatment Paradigm
Empowering a targeted and precisely delivered treatment selection in people living with RMS Thirty years ago, patients with multiple sclerosis (MS) faced a steep uphill battle choosing from a narrow selection of treatment options that tended to make minimal impact on the course of their disease. Since then, the U.S. Food and Drug Administration (FDA)…
